Annual Review

U-M Tech Transfer generated a record number of spinouts for a second consecutive year but reported less funding for its portfolio.

The TTO reported decreased spinout generation, licensing revenue and funding however marked a notable exit in the sale of Tissue Analytics.

Inserm's tech transfer office generated a $60.4m turnover during 2019, the year that saw Pfizer acquire its biotech spinout Therachon for at least $340m.

Cambridge Innovation Capital has released its annual results, celebrating a 46% increase in net asset value and its first IPO exit.

GUV’s annual review shows the ecosystem is in outstanding shape despite of all the doom and gloom in many financial papers.

Frontier IP booked increases for 2018-19 across the board in terms of cash holdings, portfolio value and pre-tax profit.

The customer relationship management software producer launched four specialist funds with $250m of capital and scored big on the IPO exit front.

Tencent added huge private equity deals to investments in the likes of Meituan-Dianping, Go-Jek and Flipkart before a run of huge IPOs late in the year.

The Google owner committed big money to Lyft and Airbnb as GV increased its late-stage deals, formed an AI fund called Gradient and exited from Snap and Cloudera in IPOs.

The telecommunications group raised almost $98bn for its Vision Fund and dominated the tech VC space in 2017.